Your browser doesn't support javascript.
loading
Prognostic Significance of Immune-checkpoint Molecule PD-L1 in Classical Hodgkin Lymphoma: A Clinicopathologic Study of 120 Cases.
Kubes, Vaclav; Kren, Leos; Sokol, Filip; Michalka, Jozef; Muzik, Jan; Arpas, Tomas; Krenova, Zdenka; Kral, Zdenek.
Affiliation
  • Kubes V; Department of Pathology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Kren L; Department of Pathology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Sokol F; Department of Pathology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Michalka J; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Muzik J; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Arpas T; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Krenova Z; Department of Children's Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Kral Z; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic; kral.zdenek@fnbrno.cz.
In Vivo ; 37(4): 1735-1742, 2023.
Article in En | MEDLINE | ID: mdl-37369476
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Hodgkin Disease Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Hodgkin Disease Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Year: 2023 Type: Article